market, the market coverage and market share of foreign companies are still relatively large. Ai Tubang compiled the third quarter financial reports of BASF, Sherwin-Williams, PPG, Akzo Nobel, Sika, and Axalta:>
Announcement of the Heyuan City Market Supervision and Administration Bureau on the unqualified status of 3 batches of food (Phase 1, 2021)
Time of Update: 2021-03-20
html" class="zdbq" title="Beverage related food information" target="_blank">beverages, and 3 batches of unqualified (see attachment for details).
Vaccination 1 shot to prevent COVID-19! Johnson and Johnson single-dose new crown vaccine large
Time of Update: 2021-03-03
3 ENSEMBLE study aims to assess the effectiveness and safety of Jansen COVID-19 candidate vaccines in protecting moderate to severe COVID-19, with the common primary endpoint being 14 and 28 days after vaccination.
First-line immunotherapy for lung cancer 1 <1! Merca East Head-to-Head Phase 3 Study: Add Yeervoy to Keytruda, no increase in benefits, increased toxicity!
Time of Update: 2021-03-02
KEYNOTE-598 is the first head-to-head study to answer the question of whether, in some patients with metastasis non-small cell lung cancer, the combined Keytruda and Yervoy provide additional clinical benefits over the treatment of Keytruda alone.
The 12 best brain supplements and cognitive enhancement pills for 2018, Omega-3 fish oil, sequoia armor, Ginkgo, etc. are on the list
Time of Update: 2021-02-18
the world is increasingly competitive, competitive pressure, the demand for modern people's brain power is getting higher and higher, in this demand, many supplements to help improve cognitive function are popular.
Fish oil Omega-3 market faces "double" threat (II)
Time of Update: 2021-02-10
Amarin said the survey was not an investigation into dietary supplements for natural fish oil, nor on Omega-3 products in the form of EE or rTG , but rather on products with low levels of EPA .
After a year, the list of new food raw materials again added - 3 kinds of probiotics and 1 kinds of local herbs┃ complete list of new food raw materials
Time of Update: 2021-02-10
, the National Health And Wellness Commission announced the "On the Swiss Lactobacillus ." R0052 53 "Three New Foods" ( no. 4 , 2020 ), including Swiss Lactobacillus R0052 and Infant
Polaris introduces high-concentration and performance Omega-3 seaweed oil
Time of Update: 2021-02-10
Designed specifically for algae DHA , this patented technology prevents oxidative stress in Omega-3 , thus avoiding the degradation of polyunsaturated fatty acids and reducing the risk of taste defects in the finished product.
The UK produces omega-3 fish oil from genetically modified linen
Time of Update: 2021-02-06
/>, why don't we culture seaweed and extract EPA and DHA directly from seaweed? This may be possible, but with current technology, even if EPA and DHA can be successfully extracted from seaweed, the extraction
Coating Committee: 3 water-based industrial coating product standards officially implemented on June 1
Time of Update: 2021-02-05
-based polyurethane coating" new standards for water as a dispersion medium, polyurethane resin as the main film, add pigment (clear Paint without) and additives applied to metal and cement mortar, concrete and other inorganic non-metallic
PD-1 co-partner CIC:1/3 of non-small cell lung cancer patients reached complete remission
Time of Update: 2021-02-05
options for late-stage NSCLC therapy, thereby improving patient prognostication and quality of life. overall, the combination of CIK cells and PD-1 blocking antibodies has good tolerance and encouraging clinical activity, and it is expected
to grab the first imitation, 3 1 class of new drugs to be released
Time of Update: 2021-01-26
Database 2020, Howson Pharmaceuticals has 2 innovative drug applications on the market, Inebilizumab Injection is the company and Vila Bio, Inc., an innovative drug jointly developed and commercialized in China, has been approved by the FDA for listing
Diabetes Care: Relationship between serum semicoagulant 3 and coronary heart disease risk in patients with type 1 diabetes in childhood
Time of Update: 2021-01-24
with type 1 diabetes in childhood. population-based national cohort study included 299 people with type 1 diabetes between 1973 and 1982 who were under the age of 15. they were examined in 2002-2003, with an average age of 33 years (range 21-44
Notice of hefei Municipal Market Supervision Administration on the non-conformity of 1 batch of food products (No. 3 of 2021)
Time of Update: 2021-01-24
and determination, in which the sampling inspection project qualified samples 206 batches, non-conforming samples 1 batch (see annex), non-conforming samples involved in the use of food additives beyond the scope of the problem. to the sampling found
Prevention of 1/3 cardiovascular events NEJM published data from nine countries supporting "all-in-one" drugs to reduce blood pressure and fat
Time of Update: 2021-01-20
data from across nine countries, covering more than 5,700 subjects, showed that taking multiple drugs containing four lipid-lowering, anti-hyperpressin and low-dose aspirins daily reduced the risk of heart attack, stroke and heart-related death by about a third.
More than half of patients A1C returned to normal Lilly GIP/GLP-1 subjector astrogen Phase 3 clinical results
Time of Update: 2021-01-16
Eli Lilly and Company today announced that its glucose-dependent insulin-promoting polypeptide (GIP) and glutatrogen-like peptide-1 (GLP-1) subject double agonist, Tirzepatide, have obtained positive top-line results in a Phase 3 clinical trial called SURFASS-1.
Prevention of 1/3 cardiovascular events NEJM published data from nine countries supporting "all-in-one" drugs to reduce blood pressure and fat
Time of Update: 2021-01-09
data from across nine countries, covering more than 5,700 subjects, showed that taking multiple drugs containing four lipid-lowering, anti-hyperbole drugs and low-dose aspirin daily reduced the risk of heart attack, stroke and heart-related death by about a third.
Hengrui Pharmaceutical PD-1 antibody two first-line therapeutic adaptation phase 3 clinical up to the main research...
Time of Update: 2021-01-05
On December 16th Henri Pharmaceuticals announced that the innovative drug, Carelli pearl monoantigen (Erika), had reached the end of two Phase 3 clinical studies: one for first-line treatment of advanced esophageal cancer with combined yew alcohol
Exchange Protein Directly Activated by Cyclic AMP-1-Regulated Recruitment of CCAAT/Enhancer-Binding
Time of Update: 2020-12-29
Here, we describe in detail how to identify and measure cAMP-mediated recruitment of a specific C/EBP isoform to a candidate regulator region of the SOCS-3 promoter in vascular endothelial cells in vitro.
